TMS Co (TSE:4891) Equity-to-Asset : 0.98 (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is TMS Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. TMS Co's Total Stockholders Equity for the quarter that ended in Nov. 2023 was 円3,160.07 Mil. TMS Co's Total Assets for the quarter that ended in Nov. 2023 was 円3,229.84 Mil.

The historical rank and industry rank for TMS Co's Equity-to-Asset or its related term are showing as below:

TSE:4891' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.9 Med: 0.97 Max: 0.98
Current: 0.98

During the past 3 years, the highest Equity to Asset Ratio of TMS Co was 0.98. The lowest was 0.90. And the median was 0.97.

TSE:4891's Equity-to-Asset is ranked better than
99.17% of 1567 companies
in the Biotechnology industry
Industry Median: 0.66 vs TSE:4891: 0.98

TMS Co Equity-to-Asset Historical Data

The historical data trend for TMS Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMS Co Equity-to-Asset Chart

TMS Co Annual Data

Trend

Feb21

Feb22

Feb23

Equity-to-Asset

0.93

0.90

0.98

TMS Co Quarterly Data
	Feb21	Feb22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Equity-to-Asset	Get a 7-Day Free Trial			0.96	0.98	0.98	0.98	0.98

Competitive Comparison of TMS Co's Equity-to-Asset

For the Biotechnology subindustry, TMS Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TMS Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TMS Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where TMS Co's Equity-to-Asset falls into.

TMS Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

TMS Co's Equity to Asset Ratio for the fiscal year that ended in Feb. 2023 is calculated as

Equity to Asset (A: Feb. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	3714.053	/	3790.215
	=

TMS Co's Equity to Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

Equity to Asset (Q: Nov. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	3160.067	/	3229.837
	=

TMS Co (TSE:4891) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

TMS Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of TMS Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

TMS Co (TSE:4891) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-9 Fuchu-cho, Fuchu-shi, Keio Fuchu 1-chome building 11th floor, Tokyo, JPN, 183-0055

Website

https://www.tms-japan.co.jp

TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables.

TMS Co (TSE:4891) Headlines

No Headlines